Difficulty: Medium
Average Score: 89%
Practice
Which of the following statements refers to plicamycin (formerly mithramycin):
Correct answer
D
Rationale
In this question, the correct answer is option D, "All of the above." Plicamycin, also known as mithramycin, is a potent antineoplastic antibiotic used in the treatment of certain types of cancer.
Option A is correct because plicamycin has a long duration of action, lasting several days, making it suitable for specific treatment regimens. Option B is also correct as the mechanism of cytotoxic action of plicamycin involves its binding to DNA, potentially through an antibiotic-Mg2+ complex, interfering with DNA transcription and replication in cancer cells.
Option C is correct as well because plicamycin can cause a decrease in plasma calcium levels by acting on osteoclasts, which is beneficial in conditions like hypercalcemia.
The incorrect options can be explained as follows:
- Option A is incorrect because plicamycin's duration of action is not short but rather extends over several days.
- Option B is wrong because plicamycin's mechanism of action does involve binding to DNA, which is crucial for its cytotoxic effects.
- Option C is also incorrect because plicamycin's action on plasma calcium levels is related to its effect on osteoclasts and is not independent of its antitumor activity.
Understanding the pharmacology of cardiovascular drugs, like plicamycin, is essential for healthcare professionals to make informed decisions regarding their use in clinical practice. It is crucial to grasp the pharmacokinetics, mechanisms of action, and potential side effects of these drugs to ensure safe and effective patient care.
Option A is correct because plicamycin has a long duration of action, lasting several days, making it suitable for specific treatment regimens. Option B is also correct as the mechanism of cytotoxic action of plicamycin involves its binding to DNA, potentially through an antibiotic-Mg2+ complex, interfering with DNA transcription and replication in cancer cells.
Option C is correct as well because plicamycin can cause a decrease in plasma calcium levels by acting on osteoclasts, which is beneficial in conditions like hypercalcemia.
The incorrect options can be explained as follows:
- Option A is incorrect because plicamycin's duration of action is not short but rather extends over several days.
- Option B is wrong because plicamycin's mechanism of action does involve binding to DNA, which is crucial for its cytotoxic effects.
- Option C is also incorrect because plicamycin's action on plasma calcium levels is related to its effect on osteoclasts and is not independent of its antitumor activity.
Understanding the pharmacology of cardiovascular drugs, like plicamycin, is essential for healthcare professionals to make informed decisions regarding their use in clinical practice. It is crucial to grasp the pharmacokinetics, mechanisms of action, and potential side effects of these drugs to ensure safe and effective patient care.